Sanofi (SNY) Total Current Liabilities (2009 - 2025)

Sanofi (SNY) posted Total Current Liabilities of $33.0 billion for Q4 2025, little changed sequentially from $32.9 billion in Q2 2025, and up 5.88% YoY from $31.2 billion in Q4 2024.

Sanofi (SNY) Total Current Liabilities (2009 - 2025) Analysis & Trends

Sanofi (SNY) has 17 years of Total Current Liabilities data on file, last reported at $33.0 billion in Q4 2025.

  • Quarterly Total Current Liabilities rose 5.88% year-over-year to $33.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $33.0 billion (up 5.88% YoY) and the FY2025 annual result came in at $33.0 billion, up 5.88% from the prior year.
  • Total Current Liabilities steadied at $33.0 billion in Q4 2025 per SNY's latest filing, from $32.9 billion in the prior quarter.
  • The five-year high for Total Current Liabilities was $33.0 billion in Q4 2025, with the low at $23.0 billion in Q2 2021.
  • Average Total Current Liabilities over 5 years is $27.8 billion, with a median of $26.5 billion recorded in 2023.
  • Year-over-year, Total Current Liabilities rose 0.4% in 2022 and advanced 19.93% in 2024.
  • Sanofi's Total Current Liabilities stood at $24.4 billion in 2021, then rose by 0.4% to $24.5 billion in 2022, then climbed by 6.48% to $26.0 billion in 2023, then increased by 19.65% to $31.2 billion in 2024, then rose by 5.88% to $33.0 billion in 2025.
  • Business Quant data shows SNY's Total Current Liabilities at $33.0 billion in Q4 2025, $32.9 billion in Q2 2025, and $31.2 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 36.63 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 57.72 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 42.10 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -32.57 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 26.95 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 24.96 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 9.48 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 34.35 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Sanofi - - 9.49 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 32.99 Bn
Jun 30, 2025 32.89 Bn
Dec 31, 2024 31.16 Bn
Jun 30, 2024 32.34 Bn
Dec 31, 2023 26.05 Bn
Jun 30, 2023 26.96 Bn
Dec 31, 2022 24.46 Bn
Jun 30, 2022 23.54 Bn
Dec 31, 2021 24.36 Bn
Jun 30, 2021 23.03 Bn
Dec 31, 2020 22.95 Bn
Jun 30, 2020 20.71 Bn
Dec 31, 2019 345.90 Mn
Jun 30, 2019 21.58 Bn
Dec 31, 2018 19.83 Bn
Sep 30, 2018 251.24 Mn
Mar 31, 2018 22.78 Bn
Dec 31, 2017 18.21 Bn
Jun 30, 2017 18.75 Bn
Dec 31, 2016 17.75 Bn